In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
From pods to peanuts: Eating potato-based packing material is latest TikTok trend
In the UK, health officials are warning people not to take part in the latest viral TikTok trend: eating potato starch-based packing peanuts used...
Natural Products Canada hands out $1.7 million to bioeconomy companies
In Prince Edward Island, Natural Products Canada has invested $1.7 million in several Canadian bioeconomy companies that represent “highly innovative biobased and natural products.”
ALT-PRO...
Amsterdam’s Photanol files for bankruptcy
In the Netherlands, Photanol BV, a biotech company with CO2-to-chemical conversion, has filed for bankruptcy, citing difficulty raising funds.
A key industrial partner exited...